Velosef (Cephradine) 1g Injection

Drug Class: First-Generation Cephalosporin Antibiotic | Form: Intramuscular (IM) / Intravenous (IV) Injection | Prescription Status: Prescription Only (Rx) — DRAP Registered

What is Velosef 1g Injection?

Velosef 1g Injection contains Cephradine at the highest available injectable strength — delivering double the antibiotic dose of the 500mg formulation in a single vial. It is a first-generation cephalosporin antibiotic reserved for the treatment of serious, severe, and complex bacterial infections (شدید اور پیچیدہ بیکٹیریل انفیکشن) where lower doses have proven insufficient or where the nature of the infection demands immediately high antibiotic concentrations across multiple body systems simultaneously.

At 1g per vial, Velosef Injection achieves substantially higher and more sustained antibiotic levels in the blood, deep tissues, lungs, kidneys, and surgical sites — making it particularly suited for severe pneumonia, complicated kidney infections, deep soft tissue infections, and gastrointestinal infections requiring parenteral antibiotic therapy. It is also widely used in surgical settings as a single high-dose pre-operative prophylactic injection to prevent post-surgical infections in procedures carrying a higher risk of bacterial contamination.

This injection is strictly a hospital and clinical setting medicine. It must be prepared and administered exclusively by a qualified doctor or nurse under appropriate clinical supervision. It represents the most potent oral-to-injectable step-up option within the Velosef range — used when the clinical situation demands maximum first-generation cephalosporin coverage through the parenteral route.

What is Velosef 1g Injection Used For?

Velosef 1g Injection is approved for the treatment and prevention of the following serious bacterial infections:

• Respiratory tract infections:
  • Pneumonia — severe bacterial lung infection requiring high-dose injectable antibiotic treatment (پھیپھڑوں کا شدید انفیکشن)
  • Severe bronchitis and lower respiratory tract infections not responding to oral antibiotics
  • Lung abscess — bacterial infection forming a pus-filled cavity within the lung tissue
• Skin and soft tissue infections:
  • Cellulitis — severe or rapidly spreading bacterial skin and deep tissue infection (جلد کا شدید پھیلنے والا انفیکشن)
  • Abscesses — large or deep pus-filled bacterial infections requiring parenteral treatment (گہرا پھوڑا)
  • Necrotising soft tissue infections — serious, fast-spreading infections of skin and underlying tissue
  • Infected surgical wounds — post-operative wound infections requiring injectable antibiotic therapy
• Urinary tract infections:
  • Pyelonephritis — severe bacterial kidney infection (گردے کا شدید انفیکشن) requiring high antibiotic concentrations in kidney tissue
  • Complicated UTIs — infections involving structural abnormalities, obstruction, catheter-associated infections, or treatment failure
  • Urosepsis — urinary tract infection that has spread into the bloodstream
• Gastrointestinal infections:
  • Bacterial peritonitis — infection of the abdominal cavity lining (پیٹ کی جھلی کا انفیکشن)
  • Intra-abdominal abscesses — localised bacterial infections within the abdominal cavity
  • Severe gastrointestinal bacterial infections requiring parenteral antibiotic therapy
• Bone and joint infections:
  • Osteomyelitis — serious bacterial bone infection (ہڈی کا انفیکشن) requiring prolonged high-dose injectable treatment to achieve adequate bone tissue penetration
  • Septic arthritis — severe bacterial joint infection requiring injectable antibiotics
• Perioperative surgical prophylaxis:
  • High-risk surgical procedures where a single high-dose pre-operative injection is required to establish maximum antibiotic protection at the surgical site before the first incision

How Does Velosef 1g Injection Work?

Cephradine kills bacteria by permanently disrupting the construction and maintenance of the bacterial cell wall — the protective outer structure that every bacterium depends on to survive, maintain structural integrity, and reproduce inside the human body.

Cephradine binds irreversibly to Penicillin-Binding Proteins (PBPs) on the bacterial surface — the specific enzymes responsible for assembling and continuously repairing the cell wall. Once these proteins are blocked, bacteria can no longer build or patch their cell wall. The wall becomes progressively weaker, loses structural integrity, ruptures, and the bacteria die.

Why the 1g dose provides superior coverage for serious infections:

At the 1g dose, Cephradine achieves significantly higher peak blood concentrations and maintains therapeutic levels for longer between doses compared to the 500mg formulation. This translates into:

• Deeper tissue penetration — higher concentrations are reached in bone tissue, kidney parenchyma, lung alveoli, and peritoneal fluid where severe infections take hold
• More effective bacterial killing — greater concentrations exceed the Minimum Inhibitory Concentration (MIC) of the infecting bacteria by a wider margin, increasing the speed and completeness of bacterial eradication
• Broader coverage for mixed infections — the higher dose provides more reliable coverage against bacterial species that may be present in gastrointestinal and complicated soft tissue infections
• Reliable surgical prophylaxis — a single 1g pre-operative injection achieves and sustains antibiotic levels throughout the duration of most surgical procedures

As a first-generation cephalosporin, Cephradine is particularly effective against Gram-positive bacteria responsible for skin, soft tissue, and respiratory infections, as well as key Gram-negative bacteria causing urinary tract and gastrointestinal infections.

Dosage and Administration

⚠️ Velosef 1g Injection is strictly a hospital and clinical setting medicine. It must only be prepared and administered by a qualified doctor or nurse. Self-administration is not possible or safe under any circumstances.

Paediatric Dosing:

• Usual dose: 50 to 100mg per kg of body weight per day, divided into 4 equal doses every 6 hours
• For very serious infections, the doctor may prescribe up to 100mg/kg/day under close supervision
• For surgical prophylaxis in children: dose calculated precisely by weight, given 30 to 60 minutes before the procedure
• The treating paediatrician or surgeon determines the exact dose, route, and duration

Route of Administration:

• Intramuscular (IM) injection — given as a deep injection into a large muscle such as the upper outer buttock or lateral thigh; used for serious infections and surgical prophylaxis where IV access is not required
• Intravenous (IV) bolus injection — given as a slow direct injection into a vein over 3 to 5 minutes; used for severe infections requiring immediate maximum blood levels
• Intravenous (IV) infusion — the reconstituted solution is further diluted in a compatible IV fluid and administered over 15 to 30 minutes; preferred for very high doses and critically ill patients
• The treating doctor selects the most appropriate route based on infection severity, clinical urgency, and the patient's overall condition

Active Ingredient

Who Should NOT Receive Velosef 1g Injection?

Do not administer this injection if the patient:

• Is allergic to Cephradine, any other cephalosporin antibiotic, or penicillin
• Has previously experienced a severe allergic reaction (anaphylaxis) to any beta-lactam antibiotic
• Has been specifically advised by a doctor not to receive this medicine

Always inform the treating doctor before administration if the patient has any of the following:

• Kidney disease or reduced kidney function — at the 1g dose, Cephradine accumulation in patients with impaired kidney function is a significant risk; dose adjustment, extended dosing intervals, and close kidney function monitoring are all essential
• History of seizures or epilepsy — high-dose injectable cephalosporins can lower the seizure threshold, particularly in patients with underlying neurological conditions or kidney impairment
• History of severe antibiotic-associated colitis or serious digestive complications from previous antibiotic use
• Penicillin allergy — a small cross-reactivity risk exists; the doctor must evaluate the full allergy history before proceeding, particularly at this higher dose
• Diabetes — Cephradine can produce false positive results in certain urine glucose tests; inform the doctor or laboratory
• Malnourished patients or those on prolonged antibiotic courses — monitoring of blood parameters including renal and hepatic function is recommended
• Is pregnant or breastfeeding — the doctor must carefully assess whether the benefit clearly outweighs the risk before prescribing at this dose

Side Effects

Velosef 1g Injection is generally well tolerated under close medical supervision. At this higher dose, careful monitoring is standard clinical practice.

Common Side Effects:

• Pain, redness, swelling, or localised hardness at the IM injection site — particularly relevant with the larger 1g dose volume; rotating injection sites is important
• Vein irritation or discomfort during IV administration
• Nausea or mild stomach discomfort
• Diarrhoea (دست) or loose stools — common with high-dose antibiotic use as the gut bacterial balance is disrupted
• Mild skin rash or itching
• Headache or mild dizziness
• Temporary and reversible elevation in liver enzyme levels on blood tests

Serious Side Effects — Seek Emergency Medical Attention Immediately:

• Severe allergic reaction (anaphylaxis) — sudden widespread rash or hives, severe swelling of the face, lips, tongue or throat, difficulty breathing, rapid heartbeat, or circulatory collapse — this is a life-threatening emergency requiring immediate intervention (یہ جان لیوا طبی ہنگامی صورتحال ہے)
• Severe or bloody diarrhoea — may indicate a dangerous Clostridioides difficile (C. diff) gut infection — stop the antibiotic and contact the doctor immediately; never give anti-diarrhoeal medicine
• Seizures or fits — particularly in patients with kidney disease receiving high doses; requires immediate medical management
• Yellowing of skin or eyes (یرقان / jaundice) — possible sign of liver involvement requiring prompt medical evaluation
• Severe skin reaction — widespread blistering, peeling, or raw areas of skin — rare but constitutes a dermatological emergency
• Thrombophlebitis — painful inflammation, redness, and hardness along the vein used for IV administration; the IV site should be changed promptly if these signs appear
• Signs of serious blood disorder — unusual or excessive bruising, persistent unexplained sore throat, severe fatigue — possible with prolonged high-dose use; requires blood count evaluation
• Signs of kidney toxicity — significantly reduced urination, swelling of legs or ankles, unexplained weight gain — particularly important to monitor at the 1g dose in at-risk patients

If any serious side effect is observed, the medical team must be informed immediately — emergency resuscitation equipment should always be accessible when high-dose injectable antibiotics are administered.

Drug Interactions

The treating doctor and clinical pharmacist must be informed of all medicines the patient is currently receiving before Velosef 1g Injection is administered.

Preparation and Storage Instructions

Reconstitution Before Use:

• Velosef 1g Injection is supplied as a sterile dry powder that must be freshly reconstituted with a suitable sterile diluent immediately before each administration
• For IM injection: reconstitute the 1g vial with the appropriate volume of Sterile Water for Injection or Lidocaine solution (as directed by the doctor) to reduce injection site pain from the larger volume
• For IV bolus injection: reconstitute with Sterile Water for Injection and administer slowly over a minimum of 3 to 5 minutes
• For IV infusion: reconstitute, then further dilute in 50 to 100ml of a compatible IV fluid — 0.9% Sodium Chloride or 5% Dextrose — and infuse over 15 to 30 minutes
• Reconstitution must be performed by a trained nurse or clinical pharmacist using strict aseptic technique in a clinical environment
• Inspect the reconstituted solution immediately before administration — it must be clear and completely free of visible particles; discard the vial immediately if the solution appears cloudy, discoloured, or contains any particulate matter

Storage:

• Store unopened vials below 25°C in a cool, dry place, protected from direct sunlight, heat, and moisture
• Keep out of reach of children (بچوں کی پہنچ سے دور رکھیں)
• Use the reconstituted solution immediately after preparation — do not store a prepared injection for later use unless specific validated stability data permits refrigerated storage for a defined period
• Do not freeze either the dry powder or the reconstituted solution
• Discard any unused reconstituted solution — do not save partial vials for a subsequent dose
• Do not use after the expiry date printed on the vial label or outer carton

Frequently Asked Questions

What makes Velosef 1g Injection the strongest formulation in the Velosef range?

 Velosef is available in multiple strengths — 125mg and 250mg syrups, 250mg and 500mg capsules, and 500mg and 1g injections. The 1g injection is the highest-strength formulation because it delivers the largest single dose of Cephradine directly into the bloodstream or muscle — achieving the highest peak blood and tissue concentrations of any form in the range. This makes it uniquely suited for the most serious infections, situations requiring immediate maximum antibiotic coverage, and high-risk surgical prophylaxis where nothing less than the highest available concentration is clinically appropriate.

How does Velosef 1g differ from Velosef 500mg Injection?

Both vials contain the same antibiotic — Cephradine — and work through exactly the same mechanism. The 1g vial contains double the antibiotic dose of the 500mg vial. This results in higher peak blood concentrations, deeper tissue penetration, a wider margin above the Minimum Inhibitory Concentration of infecting bacteria, and more sustained antibiotic levels between doses. Your doctor will prescribe the 1g strength when the severity of infection, the site of infection — such as bone or kidney tissue — or the need for surgical prophylaxis demands the highest available concentration.

Why is Velosef 1g Injection used specifically before surgery?

Surgical prophylaxis with Velosef 1g is based on a well-established principle — giving a single high-dose antibiotic injection 30 to 60 minutes before the first surgical incision ensures that maximum antibiotic levels are present in the blood, tissues, and surgical site at the exact moment when contamination risk is highest. The 1g dose maintains protective antibiotic levels throughout most surgical procedures and into the immediate post-operative period, significantly reducing the risk of surgical site infections, wound infections, and other post-operative bacterial complications.

Can Velosef 1g Injection be used for gastrointestinal infections?

Yes — Velosef 1g Injection provides coverage against several bacterial species responsible for gastrointestinal infections and intra-abdominal infections, including peritonitis and intra-abdominal abscesses. However, for polymicrobial gastrointestinal infections — where multiple different types of bacteria including anaerobes are involved — the doctor may combine Velosef with an antibiotic providing additional anaerobic coverage, such as Metronidazole. The treating doctor will determine whether Velosef alone or in combination is most appropriate based on the specific clinical situation.

How long is a typical course of Velosef 1g Injection for a bone infection?

Bone infections (osteomyelitis) are among the most challenging bacterial infections to treat because antibiotics must penetrate dense bone tissue and maintain effective levels there for an extended period. Treatment typically requires 4 to 6 weeks of antibiotic therapy — often beginning with injectable antibiotics to achieve high bone tissue concentrations before transitioning to high-dose oral antibiotics to complete the course. Your doctor will monitor response through clinical assessment, blood inflammatory markers (such as CRP and ESR), and imaging studies throughout the treatment duration.

Is Velosef 1g Injection safe for elderly patients?

Elderly patients can receive Velosef 1g Injection but require more careful monitoring than younger adults. Older patients are more likely to have reduced kidney function — even when blood tests appear near-normal — meaning Cephradine can accumulate more easily at the 1g dose. The treating doctor will assess kidney function before and during treatment and may adjust the dose or extend the interval between doses accordingly. Elderly patients are also at higher risk of antibiotic-associated diarrhoea and C. difficile infection — the medical team will monitor for these throughout the treatment course.

---

⚕️ Medical Disclaimer: This product description is provided for general informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Antibiotics must only be administered when prescribed by a licensed doctor for a confirmed or strongly suspected bacterial infection. Velosef 1g Injection must be prepared and administered exclusively by qualified healthcare professionals in a hospital or clinical setting. Report any unexpected or worsening symptoms to the medical team immediately.

---

DRAP Registered | Prescription Required (Rx) | For hospital and clinical use under strict medical supervision only